InvestorsHub Logo
Followers 220
Posts 16101
Boards Moderated 6
Alias Born 06/02/2007

Re: Zunobira post# 2947

Saturday, 08/27/2011 2:03:26 PM

Saturday, August 27, 2011 2:03:26 PM

Post# of 13148
"Well, this research on NanoTube and CTC capturing
was carried out over several years."


True enough.

"I guess there were presentation before on this work and continued research after that."

Also true.

"If they take a patent"

Uh oh! Precisely because of the points you make above, that is not an avenue now open to Cornell or to NNAN. The point of patent law known as prior art would preclude that:

http://en.wikipedia.org/wiki/Prior_art

"a cancer diagnostic/therapy tool"

There's nothing I've seen in the Cornell work that suggests to me that halloysite has any therapeutic application, but I'm willing to be persuaded otherwise if some one can point out how that might apply.

I can see how the title of NNAN's PR, deliberately designed to be misleading as normal, might lead some to think that:

"Enhanced Targeting of Cancer Cells"

but the further description from Dr. KIng makes it very plain this is about lab work, not therapeutics:

"King's Lab has developed new methods for the isolation of intact, viable cancer cells from patient blood"

"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

"Nobody ever went broke underestimating the intelligence of the American public."

H. L. Mencken

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.